What is the present valuation and projected CAGR of the urinary incontinence market?
The urinary incontinence market size has grown strongly in recent years. It will grow from $12.52 billion in 2024 to $13.37 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to aging population, awareness of urinary incontinence, rising prevalence of urinary incontinence, increasing access to healthcare, rising disposable incomes.
The urinary incontinence market size is expected to see strong growth in the next few years. It will grow to $17.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing prevalence of comorbidities, lifestyle factors, population health strategies, growing healthcare expenditures. Major trends in the forecast period include medical advancements, innovative technologies, non-invasive treatments, digital health and mhealth, innovative product designs, patient-centered care.
Get Your Free Sample of The Global Urinary Incontinence Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12946&type=smp
What key drivers have fueled the urinary incontinence market’s development over the years?
The increase in the prevalence of urological disorders is expected to propel the growth of the urinary incontinence market going forward. Urological disorders, also known as urologic conditions, refer to a wide range of medical conditions that affect the urinary system and the male reproductive organs, including the kidneys, bladder, ureters, urethra and male reproductive organs such as the prostate and testes. The increasing prevalence of urological disorders, particularly conditions like urinary incontinence, fuels the demand for products and treatments to address these issues. Further improving awareness and diagnosis, innovations in medicine and healthcare infrastructure. For instance, in January 2023, according to the report published by the American Cancer Society Inc., a US-based voluntary organization for cancer awareness, the estimated cases of urinary bladder cancer increased to 82,290 in 2023, an increase of 1.1% from 81,400 in 2020 in the United States. Therefore, the increase in the prevalence of urological disorders will drive the growth of the urinary incontinence market.
What is the segmentation for the urinary incontinence market?
The urinary incontinence market covered in this report is segmented –
1) By Type: Urge Incontinence, Stress Incontinence, Overflow Incontinence, Functional Incontinence
2) By Treatment Type: Medication, Devices, Other Treatments
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
4) By Diagnosis: Physical Exam, Pad Test, Urodynamic Testing, Cystoscopy, Stress Test, Ultrasound, Urine Samples
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Urge Incontinence: Overactive Bladder, Urinary Urgency
2) By Stress Incontinence: Involuntary Leakage During Physical Activity, Coughing Or Sneezing
3) By Overflow Incontinence: Chronic Urinary Retention, Frequent Or Constant Dribbling
4) By Functional Incontinence: Cognitive Impairment, Physical Limitations
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/urinary-incontinence-global-market-report
Who are the most influential companies in the urinary incontinence market?
Major companies operating in the urinary incontinence market are Cardinal Health Inc., Johnson and Johnson, Medtronic PLC, Eli Lilly and Company, Asahi Kasei Corporation, Becton Dickinson and Company (C.R. Bard Inc.), Teva Pharmaceutical Industries Ltd., Berry Global Inc., Boston Scientific Corporation, Mylan N.V., Sun Pharmaceutical Industries Ltd., Domtar Corporation, Cook Medical Inc., Aurobindo Pharma Ltd., Coloplast AIS, Teleflex Incorporated, Apotex Inc., Zydus Lifesciences Limited, ConvaTec Group PLC, Cook Group Inc., Torrent Pharmaceuticals Ltd., Alennbic Pharmaceuticals Limited, Laborie Medical Technologies Corp., NeoTract Inc., Ethicon Inc., Promedon GmbH, Caldera Medical Inc.
What are the top industry trends projected to impact the urinary incontinence market?
Major companies operating in the urinary incontinence market actively embrace advanced technologies and pioneering approaches to enhance patient care and treatment outcomes. For instance, in July 2023, UroMems SAS, a France-based biotechnology company, completed implanting the UroActive smart, automated artificial urinary sphincter (AUS) in a female patient to treat stress urinary incontinence (SUI) among women. The innovative UroActive device is powered by a myoelectrical mechanical system (MEMS) designed to address the unmet need for a definitive treatment for SUI in women. The procedure was performed with robotic assistance at La Pitié-Salpêtrière University Hospital in Paris, with regulatory approval from the French equivalent of the FDA. UroActive’s adjustability and smart functionality, combined with its minimally invasive approach, aim to improve patients’ quality of life.
What are the major regional insights for the urinary incontinence market, and which region holds the top position?
North America was the largest region in the urinary incontinence market in 2024. The regions covered in urinary incontinence market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Does The Urinary Incontinence Market Report 2025 Offer?
The urinary incontinence market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Urinary incontinence is a medical condition characterized by the unintentional loss of urine, ranging from occasional leaks to a complete inability to control urination. Weakened pelvic floor muscles, hormonal changes, obesity, neurological conditions, urinary tract infections, medications and pregnancy can cause urinary incontinence.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12946
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
